The Methodology

From Patient Microbiome Data
to Precision Neurotherapies.

NeuroBiome integrates deep shotgun metagenomic sequencing with AI-powered predictive models to modulate the gut-brain axis and restore proper neurological signaling.

Platform architecture

NeuroBiome Intelligence Engine

Four complementary data layers feed an AI inference layer and generate a structured Microbiome Clinical Report.

Data layers

Microbiome

SpeciesFunctional pathwaysNeuroactive metabolites prediction (e.g. SCFAs)

Clinical

Treatment

Longitudinal

Microbiome changesSymptomsTherapeutic responseFollow-up sequencing
Inference
NeuroBiome AI inference layer
Output
Microbiome Clinical Report
  • Functional profile
  • Drug–microbiome interactions
  • Neuroactive metabolites prediction
  • Target personalised microbial composition
  • Microbial intervention options
  • Scheduled follow-up
Platform vision

Precision microbiome intelligence across neuropsychiatry

01
First focus

Neurodegenerative

Multiple sclerosisAlzheimer’s diseaseParkinson’s disease
02
Expansion

Psychiatric

Chronic stress & anxietyDepression
Platform Overview

The Pipeline Workflow

NeuroBiome Pipeline Workflow — From Patient Microbiome Data to Precision Neurotherapies
How It Works

Three-Step Precision Platform

01

High-Resolution Profiling

  • Shotgun Metagenomics for 99.9% taxonomic accuracy.
  • Deep functional profiling of the microbial ecosystem.
  • Identification of core neuroactive metabolites.
02

AI Predictive Model

  • Predicts causal links between microbiome and neurological outcomes.
  • Simulates targeted microbial modulation in silico.
  • Continuous refinement fueled by longitudinal patient follow-up and our growing global database.
03

Targeted Intervention

  • Patient-specific modulation to restore correct gut-brain signaling.
  • Precision formulation of microbial adjuvants.
  • Monitoring and iterative therapeutic adjustment.
Target Patients

Who Is It Dedicated To?

Our microbiome adjuvant therapy is specifically designed for individuals with neurological or psychiatric conditions. We focus on those who are currently looking for a more comprehensive, biological approach to wellness. Our technology is dedicated to addressing:

Neurological Diseases

Neurological Diseases

Alzheimer's, Parkinson's, and Multiple Sclerosis.

Psychiatric Issues

Psychiatric Issues

Depression, anxiety disorders, chronic stress-related conditions, and other mood disorders.

Treatment Support

Patients seeking to enhance the effectiveness of standard pharmacological interventions and/or limit conventional therapy side effects.

Patient Outcomes

Expected Benefits

By reshaping microbiome composition to restore functional gut–brain axis communication, we aim to strengthen biological resilience, improve treatment response, and reduce adverse effects.

01.

Enhanced Efficacy

Improving the effectiveness of primary medications by modulating metabolic pathways in the gut.

02.

Symptom Stability

Reducing the frequency and intensity of clinical episodes through steady microbial neurotransmitter regulation.

03.

Reduced Side Effects

Mitigating GI-related side effects often associated with neuropsychiatric medications.

04.

Personalized Roadmap

Gain a precise biological understanding of your health with data-driven insights tailored to your unique microbiome signature.

"Bridging the gap between metagenomic complexity and clinical neuropsychiatry through data intelligence."